Potential of  and  populations in the Central African Republic to transmit enzootic chikungunya virus strains by unknown
SHORT REPORT Open Access
Potential of Aedes aegypti and Aedes
albopictus populations in the Central
African Republic to transmit enzootic
chikungunya virus strains
Carine Ngoagouni1*† , Basile Kamgang1,2†, Mirdad Kazanji3, Christophe Paupy4 and Emmanuel Nakouné1
Abstract
Background: Major chikungunya outbreaks have affected several Central African countries during the past decade.
The chikungunya virus (CHIKV) was isolated from humans and sylvan mosquitoes in the Central African Republic
(CAR) during the 1970 and 1980s but has not been found recently, despite the presence of Aedes albopictus since
2010. The risk of a massive chikungunya epidemic is therefore potentially high, as the human populations are
immunologically naïve and because of the presence of the mosquito vector. In order to estimate the risk of a large
outbreak, we assessed the vector competence of local Ae. aegypti and Ae. albopictus populations for ancient local
strains of CHIKV in CAR. Mosquitoes were orally infected with the virus, and its presence in mosquito saliva was
analysed 7 and 14 days post-infection (dpi) by quantitative reverse transcriptase polymerase chain reaction.
Results: The two species had similar infection rates at 7 and 14 days, and the dissemination rate of both vectors
was ≥ 80% at 14 dpi. Only females followed up to 14 dpi had CHKV in their saliva.
Conclusion: These results confirm the risk of transmission of enzootic CHIKV by anthropophilic vectors such as Ae.
aegypti and Ae. albopictus.
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Background
The chikungunya virus (CHIKV, Togaviridae, Alphavirus)
is an Aedes-borne virus maintained primarily in African
enzootic forest cycles involving monkeys and arboreal
mosquitoes [1]. The virus has spilled over secondarily to
humans, from whom it was first isolated in Tanzania in
1952 during an epidemic of dengue-like illness [2].
Chikungunya outbreaks were subsequently recorded in
rural areas throughout Africa [1], and the virus also spread
in Asia during the 1950s and 1960s [3]. Three distinct
genotypes of CHIKV have been recognized: Asian, West
African and East/Central/South African [4]. In the 2000s,
the virus induced major epidemiological changes by
extending its geographical range to new continents, caus-
ing epidemic urban waves [5]. The Asian lineage spread in
the Americas [6] and the South Pacific region [7] and the
East/Central/South African lineage to the south-west
Indian Ocean, including La Réunion [8] and India [9], and
to Europe [10]. In Central Africa, the virus was previously
observed only during rural epidemics, but it has resurged,
causing major urban outbreaks in Cameroon, Congo and
Gabon between 2006 and 2011 [11–13]. In Gabon, the
main vector species was Ae. albopictus [14], even in
remote villages in the heart of the rainforest [15].
The growing epidemic role of Ae. albopictus in Central
Africa is, however, not restricted to CHIKV: the species
was also involved in the transmission of dengue virus
[16] and Zika virus [17], suggesting that this vector has
strongly affected the epidemiology of a number of arbo-
viruses in the region. This species was introduced in
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2000 in Cameroon and spread quickly to most countries
of Central Africa [18], where it has outcompeted the na-
tive vector Ae. aegypti to become dominant in some
urban locations in Cameroon, CAR and Gabon [19].
Molecular studies of East/Central/South African viral
strains circulating in areas where Ae. albopictus was the
primary vector have shown a specific change in the
amino acid composition of the membrane fusion glyco-
protein (change E1-A226V), which was interpreted as an
adaptation of the virus for enhanced transmission by Ae.
albopictus [20]. Genetic comparisons of CHIKV strains
circulating recently in Central Africa with strains iso-
lated between 1975 and 1984 in CAR showed significant
differences compatible with rapid adaptation to Ae. albo-
pictus, as observed previously in other countries in the
region [21]. Aedes albopictus was reported for the first
time in CAR in 2010 [22] and became the most preva-
lent Aedes mosquito species, outcompeting the native
Ae. aegypti [23].
Aedes albopictus has strong ecological plasticity, which
allows it to adapt rapidly to a wide range of habitats
[18]. For instance, although Ae. albopictus originated
in Asian forests, it has now adapted to a range of
rural and urban human environments. Females of Ae.
albopictus are opportunistic feeders and can take their
blood meal from most groups of vertebrates, from cold-
to warm-blooded animals, including reptiles, birds and
amphibians, although they display a marked biting prefer-
ence for mammals, including humans [18]. This broad
spectrum of host preferences contributes to the invasion
and settlement of Ae. albopictus in diverse environments,
from natural ones to densely populated urban areas. At
the interface between natural and anthropogenic environ-
ments, its zoophilic behaviour can transfer enzootic arbo-
viruses from animals to humans. To assess this
possibility, we determined the oral susceptibility of Ae.
aegypti and Ae. albopictus from CAR to enzootic
CHIKV strain isolated in the country.
Methods
Aedes aegypti and Ae. albopictus were sampled in 2014
in Bangui (04°21'N, 18°33'E), the capital of CAR. For
each species, larvae and pupae were collected in several
peri-domestic containers and reared to adulthood in the
insectary of the Institut Pasteur de Bangui under con-
trolled conditions (70–80% humidity, 28 ± 1 °C). Once
identified as Ae. aegypti or Ae. albopictus, adults were
pooled according to species in separate cages with free ac-
cess to a 10% sucrose solution until experimental infection
with CHIKV.
The CHIKV strain used for experimental infection of
mosquitos was an enzootic strain (ArB10262) isolated in
CAR in 1978 from Ae. africanus in forested environ-
ments in Bozo (5°7'60"N, 10°28'60"E). The virus was
stored at the Institut Pasteur de Bangui in a lyophilized
form in sealed glass vials at room temperature. This
strain is one of 15 CHIKV strains sequenced and ana-
lysed recently by Desdouits and collaborators [21]. The
virus was suspended in 2 ml of phosphate buffered saline
and inoculated into an approximately 80% confluent
Vero E6 cell line (two passages) until strong cytopathic
effects were seen. Cells and supernatant were recovered
from the second passage and stored at -80 °C until
experimental mosquito infections.
Infection experiments were performed in the BSL-3
laboratory at the Institut Pasteur de Bangui with 5–10
day-old female mosquitos. About 50–100 females were
deprived of sugar solution for 24 h and fed the infectious
meal with a Hemotek feeding system (Discovery work-
shops, Accrinton, UK). The infectious blood meal was
composed of a virus suspension diluted (1:3) in washed
rabbit erythrocytes. Adenosine triphosphate, a phagosti-
mulant, was added at a final concentration of 5 × 10-3
mol/l [24]. An aliquot of the infectious blood meal was
used to estimate the blood-meal titre in a plaque assay,
which was found to be 108 plaque-forming units per ml.
Mosquitoes were allowed to feed for 45 min on a mem-
brane feeder maintained at 37 °C. Fully engorged females
were transferred in small cardboard containers and
maintained at 28 ± 1 °C and 75% relative humidity with a
10% sugar solution. Surviving females were removed at 7
and 14 days post-infection (dpi) and tested for the pres-
ence of CHIKV in saliva and head. In each experiment,
control females were fed a non-infectious blood meal.
Saliva was collected 7 and 14 dpi by the forced salivation
technique according to the protocol described by Dubrulle
and collaborators [25] to estimate dissemination and
transmission rates. As most studies show that CHIKV is
found early (around 7 dpi), we assessed whether the infec-
tion and/or dissemination rates increased or decreased be-
tween 7 and 14 dpi. Briefly, wings and legs were removed
from each mosquito, and the proboscis was introduced
into a micropipette containing 5 μl of fetal bovine serum.
After 30–45 min of salivation, fetal bovine serum contain-
ing saliva was expelled into 45 μl of Leibovitz L15 medium
(Invitrogen), and individual females were dissected to
remove the head (as well as the thorax and abdomen) to
estimate dissemination and transmission rates. All
biological material was stored at -80 °C until process-
ing for quantitative reverse transcriptase polymerase
chain reaction (qRT-PCR).
Mosquito tissue was ground in 600 μl of sterile phos-
phate buffered saline 1×. RNA was extracted with a mini
QIAamp RNA Viral kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s recommendations, eluted
in 50 μl elution buffer and stored at -80 °C until analysis.
RNA retro-transcription was performed with 25 μl of
the RNA template and random hexamer primers in the
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high-capacity cDNA reverse transcription kit (Applied
Biosystems, USA), according to the manufacturers’ in-
structions. qRT-PCR was conducted in an ABI 7500 Fast
Real-time PCR System and the Taqman Universal PCR
Master Mix (Applied Biosystems, Foster City, CA, USA).
Amplification was performed in a final volume of 25 μl
containing 5 μl cDNA, 12.5 μl 2× Master Mix, 1 μl of each
primer (10 mmol/l) and 4.5 μl of sterile water. The
primers and probe sequences used have been described by
Pastorino and collaborators [26], as follows: forward
primer: 5′-AAG CTY CGC GTC CTT TAC CAA G-3′,
reverse primer: 5′-CCA AAT TGT CCY GGT CTT CCT-
3′, and probe 5′ FAM-CCA ATG TCY TCM GCC TGG
ACA CCT TT-TAMRA 3′. The thermocycling conditions
were: 50 °C for 2 min, 95 °C for 10 min, followed by 45 -
cycles of 95 °C for 15 s and 60 °C for 10 min.
The three parameters assessed were infection, dis-
semination and transmission rates. The infection rate
was expressed as the percentage of all blood-fed mos-
quitoes tested that had infected bodies (abdomen). The
dissemination rate is the percentage of mosquitoes
among all infected mosquitoes that have CHIKV RNA
in the head. The transmission rate is the number of
mosquitoes with infected saliva divided by the number
of mosquitoes with infected head plus thorax. Fisher’s
exact test was used to compare infection, dissemination
and transmission rates between the two species at 7
and 14 dpi with STATA/IC version 11 (StataCorp,
College Station, TX). Differences were considered
statistically significant when P < 0.05.
Results and disscussion
We analysed 75 Ae. aegypti and 66 Ae. albopictus
engorged females. For Ae. aegypti, 16 of 75 engorged
females were analysed at 7 dpi and the rest (n = 59) at 14
dpi, and, for Ae. albopictus, 22 of 66 were tested at 7 dpi
and 44 at 14 dpi. At 7 dpi, the infection rates were com-
parable (Fisher’s exact test, P = 0.32, Table 1), whereas, at
14 dpi, the infection rate was more than twice as high in
Ae. aegypti (27%) than in Ae. albopictus (11%), although
the difference was not significant (Fisher’s exact test,
P = 0.08, Table 1). At 7 dpi, the dissemination rates
were 87% in Ae. aegypti and 42% in Ae. albopictus, but
with no statistically significant difference (Fisher’s
exact test, P = 0.11, Table 1). At 14 dpi, the dissemin-
ation rates were similar in the two species, at 87 and
80%. No positive saliva samples were found at 7 dpi in
either species, but at 14 dpi CHIKV was detected in
the saliva of four Ae. aegypti (28%) and three Ae. albo-
pictus (75%) mosquitos, with comparable transmission
rates (Fisher’s exact test, P = 0.24, Table 1). All pools
(unexposed) included in the experiment were negative.
The low infection rates found in both species may be
due to the origin of the CHIKV strain in the sylvan
mosquito Ae. africanus.
Emerging and re-emerging Aedes-borne diseases such
as dengue, chikungunya and Zika are major threats in
the tropics and also in temperate countries. Global
changes have played an important role in the spread of
these arboviruses from their original niches to most
parts of the world. Yellow fever, which is an arbovirus
disease that can be prevented by vaccination, recently
reappeared in Angola before spreading to Kenya and to
China [27]. As numerous arboviruses were isolated in
the past in Central Africa [17, 28], this region is consid-
ered an area of active circulation of different arboviruses
and consequently represents a source of viruses that are
“concealed” in other parts of the world by human dis-
placement. Our findings show that Ae. aegypti and Ae.
albopictus can transmit the CHIKV strain of enzootic
origin, as viral particles were detected in saliva at 14 dpi,
with 5.4 ± 0.8 log10 and 5.1 ± 0.4 log10 particles from Ae.
aegypti and Ae. albopictus, respectively.
Since the outbreak of chikungunya in La Réunion due
to a viral strain harbouring substitution of an alanine to
a valine at position 226 (E1-A226V) of the E1 glycoprotein,
which enhanced the transmissibility of CHIKV by Ae. albo-
pictus [20, 29], numerous studies have been conducted
worldwide on the vector competence of Ae. aegypti and
Ae. albopictus populations [14, 25, 30, 31]. Nevertheless,
only a few have been conducted in Cameroon [14] and
more recently in Senegal [32], providing information on
Africa. In our study, the dissemination rates were higher
(≥ 80%) at 14 dpi, and mosquitoes were susceptible to
transmitting CHIKV only 14 days after they had taken the
infected meal. In a study by Vega-Rua and collaborators
[33], the dissemination rates increased to 100% at 6 dpi in
Ae. aegypti and Ae. albopictus infected with two CHIKV
Table 1 Infection, dissemination and transmission rates calculated at 7 and 14 days post-infection (dpi) for Aedes aegypti and Ae.
albopictus females orally challenged with CHIKV at a titre of 107.3 plaque-forming units per ml
Infection rate (%) Dissemination rate (%) Transmission rate (%)
Mosquito species 7 dpi 14 dpi 7 dpi 14 dpi 7 dpi 14 dpi
Aedes aegypti 8/16 (50) 16/59 (27) 7/8 (87) 14/16 (87) 0/7 (0) 4/14 (28)
Aedes albopictus 7/22 (31) 5/44 (11) 3/7 (42) 4/5 (80) 0/3 (0) 3/4 (75)
Pa 0.32 0.08 0.11 1.00 – 0.24
aFisher’s exact test (P < 0.05 indicates significant difference)
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strains, one of which was isolated from imported cases
(CHIKV 2010–1630) and the second in France (CHIKV
2010–1909); the titre of the blood meal used was 107.3
plaque-forming units per ml. Other studies have shown ef-
ficient dissemination of the E1-226 V variant, which was
detectable in the salivary glands of Ae. aegypti and Ae.
albopictus from 2 dpi [25]. More recently, Vega-Rua and
collaborators [33] showed that around 80% of both species
can transmit CHIKV at 6 dpi, but the dissemination rate
decreased progressively to day 14. The extrinsic incubation
periods observed in the present study are different from
that observed by Diagne et al. [32] using local CHIKV
strains, which was 5 days for Ae. aegypti.
The CHIKV strain used in our study was isolated from
a sylvatic vector, Ae. africanus. Desdouits and collabora-
tors [21] showed that this strain differs from the East/
Central/South African strain responsible for the recent
chikungunya outbreaks reported in numerous Central
African countries. The ability of these major vectors to
transmit arboviruses has not previously been assessed in
CAR, although many important viral strains, including
CHIKV, are endemic and despite the risk of imminent
outbreaks of arboviral infections such as chikungunya in
the country [23]. Our finding that Ae. aegypti and Ae.
albopictus, which are the main vectors involved in the
transmission of dengue virus and CHIKV in urban envi-
ronments, can also transmit a local CHIKV strain suggests
that both vectors can serve as a bridge between non-
human primates and humans and that there is a risk for
the emergence of this type of virus, as suggested by Paupy
et al. [15]. In addition, if the virus is transferred to a
human-dominated environment (city or village), inter-
human transmission might occur, leading to outbreaks.
Conclusion
Both local Ae. aegypti and Ae. albopictus populations
can transmit an enzootic CHIKV. The risk of emergence
of arbovirus diseases such as chikungunya should there-
fore be considered for several reasons, including the
abundance of the main anthropogenic vectors (Ae.
aegypti and Ae. albopictus), the movement of popula-
tions that are immunologically naïve and the diversity of
wild fauna. In order to prevent the emergence of chikun-
gunya in CAR, entomological and virological monitoring
must be strengthened.
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